Skip to content

Topic

Glioblastoma

The most aggressive form of diffuse glioma, a primary brain tumour marked by short median survival and by tumour cells that resist radiation and chemotherapy.

Current stories

scienceOne report1 publisher

Control experiment reassigns zavondemstat's main target to DHODH

University of Sydney researchers report that the cancer drug zavondemstat works mainly by blocking the enzyme DHODH, not the KDM4 proteins it was built to hit. The experiments were done in glioblastoma cells, and the drug is already in human trials.

Publishers:medicalxpress.com

Reality

Evidence55
Adoption
Not scored
Hype gap+25
Incentives
Not scored
Confidence50
scienceOne report1 publisher

Lymph-node-like immune hubs in mouse skull bone marrow respond to glioblastoma before distant nodes do

The WashU group reports in Nature that the structures activate in mice before distant lymph nodes get the signal, and that a gel of three immune proteins placed under the scalp boosted the antitumor response.

Publishers:sciencedaily.com

Reality

Evidence52
Adoption
Not scored
Hype gap+30
Incentives68
Confidence55
scienceOne report1 publisher

Magnetically switched nanoantennas slowed drug-resistant glioblastoma in mouse brains

The MIT Media Lab's injectable devices convert an external magnetic field into an electric field at the tumor itself, which killed chemoresistant patient cells in a dish and slowed the same tumors in mouse brains.

Publishers:phys.org

Reality

Evidence56
Adoption6
Hype gap+27
Incentives74
Confidence58
scienceOne report1 publisher

Blocking SET left glioblastoma cells more vulnerable to radiation in preclinical models

Ohio State reports that glioblastoma suppresses the enzyme PP2A using three of its own proteins, and that knocking those down in lab and animal models killed more cells and left the survivors easier to irradiate. No patients have been treated.

Publishers:sciencedaily.com

Reality

Evidence42
Adoption
Not scored
Hype gap+22
Incentives65
Confidence52